Dark

Check out our API

PTPI
PETROS PHARM INC
stock OTC

EOD

Dec 12, 2025

0.0127USD+0.794%(+0.0001)271,103

Pre-market

0.00USD-100.000%(-0.01)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 24, 2022

09:16AM EST Petros Partners With Global Contract Manufacturer To Bring Production Of Erectile Dysfunction Drug Avanafil To US RTTNews

09:15AM EST Bring Production of Erectile Dysfunction Drug STENDRA0 (avanafil) to the United States PR Newswire

Jan 18, 2022

09:20AM EST Petros Pharmaceuticals Launches 2 Self-Selection Studies For Erectile Dysfunction Drug STENDRA Benzinga

09:20AM EST Petros Pharmaceuticals Launches Two Self-Selection Studies for Erectile PR Newswire

Dec 28, 2021

09:15AM EST Petros Pharmaceuticals Announces Closing of $7.5 Million Offering PR Newswire

Dec 22, 2021

09:11AM EST Petros Pharmaceuticals Announces $7.5M Common Stock Offering; 2,186,589 Shares At $3.43/Share Benzinga

09:10AM EST Petros Pharmaceuticals Announces $7.5 Million Offering PR Newswire

Dec 21, 2021

10:12AM EST Mid-Morning Market Update: Markets Open Higher; General Mills Earnings Miss Views Benzinga

Dec 9, 2021

09:37PM EST From Benzinga's Global Small Cap Conference: Petros Pharma President & CCO, Fady Boctor, MBA Says Co Has The Potential To Have The First Over-The-Counter Erectile Dysfunction (ED) Drug, Says It Is Currently Under Development Benzinga

09:37PM EST From Benzinga's Global Small Cap Conference: Petros Pharma President & CCO, Fady Boctor, MBA Begins Presenting Benzinga

Dec 8, 2021

09:24AM EST Petros Pharmaceuticals Announces Over-The-Counter Label Comprehension Study Results For Erectile Dysfunction Drug STENDRA Benzinga

09:16AM EST Comprehension Study Results for Erectile Dysfunction Drug STENDRA(r) (avanafil) PR Newswire

Dec 2, 2021

12:01PM EST Petros Pharmaceuticals Announces Closing of $10 Million Offering PR Newswire

09:01AM EST Petros Pharmaceuticals to Present at the Benzinga Global Small Cap Conference PR Newswire

Nov 30, 2021

04:49PM EST Petros Pharmaceuticals Announces 3.33M Share Offering At $3/Share Benzinga

04:26PM EST What's Going On With Petros Pharmaceuticals Stock Today? Benzinga

04:04PM EST Mid-Morning Market Update: Markets Open Higher; Li Auto Sales Top Views Benzinga

09:08AM EST Petros Pharmaceuticals Announces $10 Million Offering PR Newswire

Nov 24, 2021

10:23AM EST Mid-Morning Market Update: Markets Open Lower; Deere Earnings Top Views Benzinga

Nov 23, 2021

02:31PM EST Mid-Afternoon Market Update: Dow Surges 100 Points; Zoom Video Shares Plunge Benzinga

12:32PM EST Mid-Day Market Update: Nasdaq Tumbles Over 200 Points; Pasithea Therapeutics Shares Surge Benzinga

04:41AM EST Petros Pharmaceuticals Shares Rise 300% Premarket; Co Filed Proxy Statement for Annual Meeting After the Market Close on Monday Benzinga

Nov 15, 2021

05:37PM EST Petros Pharmaceuticals Q3 Sales $2.20M Down From $3.50M YoY Benzinga

04:31PM EST Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides PR Newswire

Nov 11, 2021

09:16AM EST Petros Pharmaceuticals to Present at the Q4 Investor Summit Conference PR Newswire

Nov 8, 2021

09:18AM EST Petros Pharmaceuticals Expands Program For Novel Investigational Non-Invasive Treatment Formulation For Peyronie's Disease Benzinga

09:17AM EST Petros Expands Program For Novel Investigational Non-Invasive Treatment Formulation For Peyronie's Disease RTTNews

09:15AM EST Petros Pharmaceuticals Expands Program for Novel Investigational Non-Invasive PR Newswire

Nov 3, 2021

03:54PM EDT Why Petros Pharmaceuticals Stock Is Soaring Today Benzinga

11:27AM EDT Shares of nano-cap company Petros Pharmaceuticals, Inc. (PTPI) more than doubled on Wednesday morning after the pharma company announced a 476% growth year-over-year of STENDRA tablet sales as part of an exclusive digital health marketing agreement with Hims & Hers Health, Inc. RTTNews

09:17AM EDT Petros Pharmaceuticals, Inc. Through Exclusive Marketing Agreement with Hims & PR Newswire

Oct 21, 2021

09:25AM EDT Petros Pharmaceuticals to Participate at Upcoming Benzinga Conference and PR Newswire

Oct 19, 2021

09:25AM EDT Petros Pharmaceuticals Announces Closing of $5.7 Million Registered Direct PR Newswire

Oct 14, 2021

09:04AM EDT Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering PR Newswire

09:01AM EDT Petros Pharmaceuticals Announces $5.7M Registered Direct Offering Benzinga

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Sep 23, 2021

08:43AM EDT Petros Pharmaceuticals To Present At Benzinga Healthcare Small Cap Conference Sept. 30 Benzinga

08:31AM EDT Petros Pharmaceuticals to Present at the Benzinga Healthcare Small Cap PR Newswire

Sep 10, 2021

08:31AM EDT Petros Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global PR Newswire

Aug 17, 2021

09:30AM EDT Petros Pharma Q2 Net Sales $2.5 Mln Vs. $1.34 Mln Last Year RTTNews

09:27AM EDT Petros Pharmaceuticals Q2 EPS $(0.22), Sales $2.46M Benzinga

09:25AM EDT Corporate Update; Reports a 123% Increase in Year Over Year Quarterly STENDRA(r) (avanafil) Net Sales PR Newswire

Aug 12, 2021

08:02AM EDT Petros Pharmaceuticals to Present at Two Upcoming August Conferences PR Newswire

Jul 29, 2021

10:11AM EDT Petros Pharmaceuticals Seeks to Disrupt the Prescription Erectile Dysfunction (ED) Market Benzinga

Jul 27, 2021

11:13AM EDT Petros Pharmaceuticals Says FDA Grants Meeting To Co To Discuss Label Expansion Of Erectile Dysfunction Drug STENDRA Benzinga

Jul 13, 2021

09:19AM EDT Petros Pharmaceuticals Completes Pilot Label Comprehension Study To Initiate Process For Stendra Prescription Erectile Dysfunction Medication To Achieve Designation As An Over-the-Counter Treatment Benzinga

09:16AM EDT Process for Stendra(r) Prescription Erectile Dysfunction Medication to Achieve Designation as an Over-the-Counter Treatment PR Newswire

Jul 12, 2021

08:16AM EDT Petros Pharmaceuticals to Present at the Access to Giving Virtual Investor PR Newswire

Jun 23, 2021

04:44AM EDT 44 Biggest Movers From Yesterday Benzinga

Jun 2, 2021

10:13AM EDT Petros Pharmaceuticals to Present at the LD Micro Virtual Invitational PR Newswire

May 25, 2021

10:14AM EDT Mid-Morning Market Update: Markets Edge Higher; AutoZone Tops Q3 Expectations Benzinga

May 17, 2021

01:47PM EDT Mid-Day Market Update: Gold Rises 1.5%; FreightCar America Shares Slide Following Q1 Results Benzinga

08:24AM EDT Petros Pharmaceuticals Reports Q1 EPS $0.31, Up From $(1.23) YoY, Sales $4.076M, Up From $1.79M YoY Benzinga

08:22AM EDT Petros Pharmaceuticals Announces First Quarter Financial Results and Provides PR Newswire

May 14, 2021

08:31AM EDT Petros Pharmaceuticals to Participate at the Investor Summit Conference and PR Newswire

May 7, 2021

08:01AM EDT Petros Pharmaceuticals to Participate at the Benzinga Global Small Cap PR Newswire

Mar 18, 2021

09:02AM EDT Men with Erectile Dysfunction to Initiate Petros Pharmaceuticals' Plans for Expanded Labeling PR Newswire

Feb 18, 2021

08:02AM EST Petros Pharmaceuticals Welcomes Dr. Mohit Khera to Steering Committee to Expand PR Newswire

Feb 4, 2021

08:41AM EST Petros Pharmaceuticals Establishes Steering Committee To Expand Into Non-Rx Status For Stendra Benzinga

08:31AM EST Petros Pharmaceuticals Establishes Steering Committee to Expand into Non-Rx PR Newswire

Jan 19, 2021

08:00AM EST Petros Pharmaceuticals (Nasdaq: PTPI) today announces that its president and chief commercial officer Fady Boctor will present at NobleCon17 - Noble Capital Markets Seventeenth Annual Investor Conference on Wednesday, January 20, 2021 at 9:00 AM ET in Track 2. GlobeNewswire Inc

Dec 8, 2020

04:16PM EST Neurotrope, Inc. Completes Independent Spin-off of Neurotrope Bioscience, Inc. PR Newswire

Share